Mortality and guideline-directed medical therapy in real-world heart failure patients with reduced ejection fraction.
Peter A McCulloughHirsch S MehtaColin M BarkerJoanna Van HoutenSarah MollenkopfCandace L GunnarssonMichael RyanDavid P CorkPublished in: Clinical cardiology (2021)
In a real-world population of HFrEF patients, inadequate GDMT confers a 29% excess mortality risk over the 2-year follow-up.